Brodalumab Biosimilar – Anti-IL17RA, CD217 mAb – Research Grade

Reference:
Product nameBrodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade
SourceCAS 1174395-19-7
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsBrodalumab,AMG827,KHK4827,IL17RA, CD217,anti-IL17RA, CD217
ReferencePX-TA1268
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Brodalumab Biosimilar - Anti-IL17RA/CD217 mAb - Research Grade

General information on Anti-IL17RA/CD217[Homo sapiens] (Brodalumab) Monoclonal Antibody

Brodalumab has been investigated for the treatment of Asthma, Psoriasis, Crohn’s Disease, Psoriatic Arthritis, and Rheumatoid Arthritis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Brodalumab Biosimilar – Anti-IL17RA, CD217 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

IL17RA recombinant protein
Antigen

IL17RA recombinant protein

PX-P5211 385€
Stable Isotope Labelled Brodalumab Biosimilar – Anti-IL17RA/CD217 mAb – Research Grade
SIL

Stable Isotope Labelled Brodalumab Biosimilar – Anti-IL17RA/CD217 mAb – Research Grade

PX-TA1268-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products